TrialDiabetes, obesity & metabolism2025

Efficacy and safety of switching to iGlarLixi from premixed insulins in people with type 2 diabetes: The Soli-SWITCH study.

Martin Haluzík et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.